(19)
(11) EP 1 423 700 A2

(12)

(88) Date of publication A3:
18.12.2003

(43) Date of publication:
02.06.2004 Bulletin 2004/23

(21) Application number: 02762684.5

(22) Date of filing: 04.09.2002
(51) International Patent Classification (IPC)7G01N 33/566, G01N 33/50
(86) International application number:
PCT/IB2002/003618
(87) International publication number:
WO 2003/021271 (13.03.2003 Gazette 2003/11)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 04.09.2001 GB 0121440
20.09.2001 US 323973 P

(71) Applicants:
  • Pfizer Limited
    Sandwich,Kent CT13 9NJ (GB)

    GB 
  • PFIZER INC.
    New York, N.Y. 10017 (US)

    AT BE BG CH CY CZ DE DK EE ES FI FR GR IE IT LU MC NL PT LI 

(72) Inventors:
  • GREENGRASS, Pamela, M.Pfizer Global Res. and Dev.
    Sandwich,Kent CT13 9NJ (GB)
  • STEWART, Michael,Pfizer Ltd., U.K. Patent Dept.
    Sandwich,Kent CT13 9NJ (GB)
  • WOOD, Claire M.,Pfizer Global Res. and Dev.
    Sandwich,Kent CT13 9NJ (GB)

(74) Representative: Walls, Alan James 
Pfizer Limited,UK Patent Department,Ramsgate Road
Sandwich,Kent CT13 9NJ
Sandwich,Kent CT13 9NJ (GB)

   


(54) AFFINITY-ASSAY FOR THE HUMAN ERG POTASSIUM CHANNEL